Hyperlipidemia impairs uterine β-adrenergic signaling by reducing cAMP in late pregnant rats

Sakshi Chauhan,Subhashree Parida,E Prakash,G Srinivasan,Vivek Srivastava,Manjit Panigrahi,Thakur Uttam Singh,Santosh K Mishra
DOI: https://doi.org/10.1530/rep-19-0346
2020-01-01
Reproduction
Abstract:The aim of the present study was to reveal the effect of hyperlipidemia on β 2 - and β 3 -adrenergic signaling in late pregnant rat uterus. Hyperlipidemia was induced in female Wistar rats by feeding a high-fat high-cholesterol diet for 8 weeks before and after mating upto the 21st day of gestation. The effect of hyperlipidemia on β-adrenergic signaling was studied with the help of tension experiments, real-time PCR and cAMP ELISA in 21-day pregnant rat uterus. In tension experiments, hyperlipidemia neither altered the spontaneous contractility nor the oxytocin-induced contractions. However, it decreased the −logEC 50 values of β 2 -adrenoceptor agonist, salbutamol and β 3 -adrenoceptor agonist, BRL37344. It also decreased the efficacy of adenylyl cyclase activator, forskolin. Further, there was a significant decrease in salbutamol and BRL37344-stimulated cAMP content in uterine tissues. However, there was no alteration in mRNA expressions of β 2 -adrenoceptor ( Adrb2 ), β 3 -adrenoceptor ( Adrb3 ) and Gs protein ( Gnas ) though there was a significant increase in the mRNA expression of Gi protein ( Gnai ). In conclusion, reduced cAMP content after beta-adrenergic receptor stimulation, which correlates with an increase in Gnai mRNA, may explain the mechanism of the impairment of uterine β-adrenergic signaling in hyperlipidemic pregnant rats. The clinical implication of the present study may relate to reduced myometrial relaxant response to β-adrenergic agonists in high fat-induced uterine dysfunction.
developmental biology,reproductive biology
What problem does this paper attempt to address?